Document Type
Article
Publication Date
1-1-2000
Abstract
The growing number of individuals affected by dementia will intensify the ethical issues that emerge in clinical practice and research, issues early in disease relate to genetic testing, use of medications in mildly affected persons, and diagnostic disclosure. Research issues relate to appropriate informed consent processes, conflict of interests, and research design issues, such as the use of placebos and the use of biological tissues. In the later stages of disease concern about appropriate therapeutic goals and end-of-life care is appropriate.
Keywords
ethics, dementia, Alzheimer's disease, clinical practice, research, informed consent, end-of-life care, use of placebo, genetic testing
Language
English
Publication Title
Dialogues In Clinical Neuroscience
Rights
© 2000 LLS. This is an open access article under the CC BY-NC-ND license (https://creativecommons.org/licenses/by-nc-nd/3.0/), which permits non-commercial distribution and reproduction in any medium, provided the original work is properly cited.
Recommended Citation
Whitehouse, P. J. (2000). Ethical issues in dementia. Dialogues in Clinical Neuroscience, 2(2), 162–167. https://doi.org/10.31887/DCNS.2000.2.2/pwhitehouse
Manuscript Version
Final Publisher Version